Literature DB >> 3726006

Dextroamphetamine-induced arousal in human subjects as a model for mania.

D Jacobs, T Silverstone.   

Abstract

Because of the practical difficulties which arise in studying manic patients, a reproducible model for mania using human subjects would be a valuable adjunct to research in this condition. Dextroamphetamine, given as a single oral 20 mg dose, fulfils the criteria for such a model in that there are very close similarities between the changes which occur after dextroamphetamine and those which have been observed in mania in terms of subjective experience, physiological and endocrine changes, and response to pharmacological agents.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3726006     DOI： 10.1017/s0033291700009132

Source DB:  PubMed          Journal:  Psychol Med        ISSN： 0033-2917            Impact factor:   7.723


  37 in total

Review 1.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 2.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

Review 3.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

4.  Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.

Authors:  Michele L Ulrich; Susan Rotzinger; Sheila J Asghar; Paul Jurasz; Veronique A Tanay; Susan M J Dunn; Marek Radomski; Andy Greenshaw; Peter H Silverstone
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

Review 5.  The development and course of bipolar spectrum disorders: an integrated reward and circadian rhythm dysregulation model.

Authors:  Lauren B Alloy; Robin Nusslock; Elaine M Boland
Journal:  Annu Rev Clin Psychol       Date:  2015-01-12       Impact factor: 18.561

6.  Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania.

Authors:  Benício N Frey; Samira S Valvassori; Gislaine Z Réus; Márcio R Martins; Fabrícia C Petronilho; Katrine Bardini; Felipe Dal-Pizzol; Flávio Kapczinski; João Quevedo
Journal:  Neurochem Res       Date:  2006-05-24       Impact factor: 3.996

7.  Effects of mood stabilizers on DNA damage in an animal model of mania.

Authors:  Ana Cristina Andreazza; Marcia Kauer-Sant'Anna; Benicio N Frey; Laura Stertz; Caroline Zanotto; Leticia Ribeiro; Karine Giasson; Samira S Valvassori; Gislaine Z Réus; Mirian Salvador; João Quevedo; Carlos A Gonçalves; Flavio Kapczinski
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

Review 8.  Potential mechanisms of action of lithium in bipolar disorder. Current understanding.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Carissa M Coulston; Michael Berk
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

9.  Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.

Authors:  Yi Che; Yong-Hua Cui; Hua Tan; Ana C Andreazza; L Trevor Young; Jun-Feng Wang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-01       Impact factor: 4.530

Review 10.  From drugs to deprivation: a Bayesian framework for understanding models of psychosis.

Authors:  P R Corlett; C D Frith; P C Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2009-05-28       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.